Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alphatec (DE:L1Z1)
:L1Z1
L1Z1 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€4.36 - €14.00
Previous CloseN/A
Volume150.00
Average Volume (3M)37.00
Market Cap
€1.44B
Enterprise Value€1.30B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Feb 26, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding141,767,870
10 Day Avg. Volume0
30 Day Avg. Volume37
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.64
Price to Cash Flow (P/CF)-70.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.91
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.20
Enterprise Value/Ebitda-16.86
Forecast
1Y Price Target
€17.15Price Target Upside69.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAlphatec reported Q4 revenue expected to exceed estimates, showing significant growth driven by increases in surgical revenue, volume, and revenue per procedure.
Innovative TechnologyAlphatec is bringing unique technologies like SafeOp, EOS, and Remi to spine surgeons to help them improve clinical care.
LeadershipCEO Pat Miles is considered a great leader who has made smart, courageous decisions believed to create significant value for stakeholders.
Bears Say
Convertible Term LoanThe company has a convertible term loan of approximately $316M that is due in August 2026, which may require the company to secure additional financing before then.
Debt ManagementDespite improvements, the company holds significant debt, and cash use has been a concern, although management is taking steps to address this.
Market PositionATEC is trading below its high-growth peer group despite significantly higher sales growth expected in 2025 and 2026.
---
Options Prices
Currently, No data available
---
Ownership Overview
20.30% Insiders
14.26% Mutual Funds
18.23% Other Institutional Investors
37.92% Public Companies and Individual Investors
L1Z1 FAQ
What was Alphatec’s price range in the past 12 months?
Alphatec lowest stock price was €4.36 and its highest was €14.00 in the past 12 months.
What is Alphatec’s market cap?
Alphatec’s market cap is €1.44B.
When is Alphatec’s upcoming earnings report date?
Alphatec’s upcoming earnings report date is Feb 26, 2025 which is in 4 days.
How were Alphatec’s earnings last quarter?
Alphatec released its earnings results on Oct 30, 2024. The company reported -€0.103 earnings per share for the quarter, missing the consensus estimate of -€0.102 by >-€0.001.
Is Alphatec overvalued?
According to Wall Street analysts Alphatec’s price is currently Undervalued.
Does Alphatec pay dividends?
Alphatec does not currently pay dividends.
What is Alphatec’s EPS estimate?
Alphatec’s EPS estimate is -0.05.
How many shares outstanding does Alphatec have?
Alphatec has 141,767,870 shares outstanding.
What happened to Alphatec’s price movement after its last earnings report?
Alphatec reported an EPS of -€0.103 in its last earnings report, missing expectations of -€0.102. Following the earnings report the stock price went up 32.71%.
Which hedge fund is a major shareholder of Alphatec?
Currently, no hedge funds are holding shares in DE:L1Z1
---
Alphatec Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€17.15 (69.83% Upside)
€17.15 (69.83% Upside)
Blogger Sentiment
Bullish
DE:L1Z1 Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.77%
12-Months-Change
Fundamentals
Return on Equity
-9999.00%
Trailing 12-Months
Asset Growth
11.29%
Trailing 12-Months
Company Description
Alphatec
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.
---
L1Z1 Company Deck
---
L1Z1 Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong picture of growth and financial improvements, with significant revenue increases and positive momentum in surgical and EOS segments. However, challenges such as gross margin pressure and high debt levels persist. Overall, the positive aspects of growth and improved profitability outweigh these challenges.Read More>---
L1Z1 Stock 12 Month Forecast
Average Price Target
€17.15
▲(69.83% Upside)
Technical Analysis
Best Analysts Covering L1Z1
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+13.20%
reiterated a buy rating last month
Copying Mathew Blackman's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +13.20% per trade.
---